Nicotinamide Mononucleotide and Nicotinamide Riboside Improve Dyslipidemia and Fatty Liver but Promote Atherosclerosis in Apolipoprotein E Knockout Mice.

Compared with the control group, the liver weight of mice significantly decreased after 1 month of treatment ( Figure 2 A, p < 0.05), and the liver-to-body weight ratio showed a trend to decrease ( Figure 2 B).

also in 53,322 other papers